Gene · 6579
Papers2,617
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 2,617
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bisphenol A-sulfate conjugate disrupts AURKA transcription and cell cycle in BeWo cytotrophoblasts. | Mol Cell Endocrinol | 2022 | 35041905 | PubTator, text mining | PubMed |
| In Vitro to In Vivo Extrapolation Linked to Physiologically Based Pharmacokinetic Models for Assessing the Brain Drug Disposition. | AAPS J | 2022 | 35028763 | PubTator, text mining | PubMed |
| [Bulevirtide as the first specific agent against hepatitis D virus infections-mechanism and clinical effect]. | Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz | 2022 | 35028672 | PubTator, text mining | PubMed |
| Interactions between Food and Drugs, and Nutritional Status in Renal Patients: A Narrative Review. | Nutrients | 2022 | 35011087 | PubTator, text mining | PubMed |
| Generation of Human Pluripotent Stem Cell-Derived Polarized Hepatocytes. | Curr Protoc | 2022 | 35007406 | PubTator, text mining | PubMed |
| QiShenYiQi pills, a Chinese patent medicine, increase bioavailability of atorvastatin by inhibiting Mrp2 expression in rats. | Pharm Biol | 2022 | 35001796 | PubTator, text mining | PubMed |
| Clinical, histological and molecular profiling of different stages of alcohol-related liver disease. | Gut | 2022 | 34992134 | PubTator, text mining | PubMed |
| Drug-Drug Interactions in People Living With HIV at Risk of Hepatic and Renal Impairment: Current Status and Future Perspectives. | J Clin Pharmacol | 2022 | 34990024 | PubTator, text mining | PubMed |
| Pharmaceutical strategies for preventing toxicity and promoting antioxidant and anti-inflammatory actions of bilirubin. | J Enzyme Inhib Med Chem | 2022 | 34986721 | PubTator, text mining | PubMed |
| Identification of Immune Cells and Key Genes associated with Alzheimer's Disease. | Int J Med Sci | 2022 | 34975305 | PubTator, text mining | PubMed |
| Warfarin Pharmacogenomics for Precision Medicine in Real-Life Clinical Practice in Southern Africa: Harnessing 73 Variants in 29 Pharmacogenes. | OMICS | 2022 | 34958284 | PubTator, text mining | PubMed |
| An update on the physiologic changes during pregnancy and their impact on drug pharmacokinetics and pharmacogenomics. | J Basic Clin Physiol Pharmacol | 2022 | 34881531 | PubTator, text mining | PubMed |
| Population Pharmacokinetics of Elagolix in Combination with Low-Dose Estradiol/Norethindrone Acetate in Women with Uterine Fibroids. | Clin Pharmacokinet | 2022 | 34878624 | PubTator, text mining | PubMed |
| Ras inhibitor farnesylthiosalicylic acid conjugated with IR783 dye exhibits improved tumor-targeting and altered anti-breast cancer mechanisms in mice. | Acta Pharmacol Sin | 2022 | 34845369 | PubTator, text mining | PubMed |
| Atorvastatin population pharmacokinetics in a real-life setting: Influence of genetic polymorphisms and association with clinical response. | Clin Transl Sci | 2022 | 34761521 | PubTator, text mining | PubMed |
| Lactic acidosis, a potential toxicity from drug-drug interaction related to concomitant ribociclib and metformin in preexisting renal insufficiency: A case report. | Cancer Rep (Hoboken) | 2022 | 34739192 | PubTator, text mining | PubMed |
| Polymorphisms contribute to differences in the effect of rocuronium in Chinese patients. | Basic Clin Pharmacol Toxicol | 2022 | 34734679 | PubTator, text mining | PubMed |
| Factors influencing the levothyroxine dose in the hormone replacement therapy of primary hypothyroidism in adults. | Rev Endocr Metab Disord | 2022 | 34671932 | PubTator, text mining | PubMed |
| Predicting Drug-Drug Interactions between Rifampicin and Ritonavir-Boosted Atazanavir Using PBPK Modelling. | Clin Pharmacokinet | 2022 | 34635995 | PubTator, text mining | PubMed |
| Role of Uptake Transporters OAT4, OATP2A1, and OATP1A2 in Human Placental Bio-disposition of Pravastatin. | J Pharm Sci | 2022 | 34597623 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6579/papers?page=33